Search Results - "Farassati, Faris"

Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44+ cancer stem cells by Najafzadeh, Nowruz, Mazani, Mohammad, Abbasi, Asadollah, Farassati, Faris, Amani, Mojtaba

“…Abstract Cis-diamminedichloridoplatinum(II)(CDDP)-based combination chemotherapy is frequently used in gastrointestinal cancer. The synergistic mechanism of…”
Get full text

Colorectal Cancer in Iran: Molecular Epidemiology and Screening Strategies by Dolatkhah, Roya, Somi, Mohammad Hossein, Bonyadi, Mortaza Jabbarpour, Asvadi Kermani, Iraj, Farassati, Faris, Dastgiri, Saeed

“…Purpose. The increasing incidence of colorectal cancer (CRC) in the past three decades in Iran has made it a major public health burden. This study aimed to…”
Get full text

The Prognostic Value of Different Molecular Subtypes of Breast Cancer in Relation to Enhancer-of-Zeste Homologue 2 Expression by Sanaat, Zohreh, Fakhrjou, Ashraf, Farassati, Faris, Dolatkhah, Roya

“…Introduction: The role of Enhancer-of-zeste homologue 2 (EZH2) in breast cancer invasion and progression may be attributed to EZH2-mediated epigenetic…”
Get full text

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer by Dolatkhah, Roya, Dastgiri, Saeed, Eftekhar Sadat, Amir Taher, Farassati, Faris, Nezamdoust, Marzieh, Somi, Mohammad Hossein

“…[...]it is second most common cancer in East Azerbaijan.2 Despite the longstanding screening and early detection programs as well as improvements in cancer…”
Get full text

Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1 by Pan, Weihong, Bodempudi, Vidya, Esfandyari, Tuba, Farassati, Faris

“…Re-engineering the tropism of viruses is an attractive translational strategy for targeting cancer cells. The Ras signal transduction pathway is a central hub…”
Get full text

Inhibition of mesothelin as a novel strategy for targeting cancer cells by Wang, Kun, Bodempudi, Vidya, Liu, Zhengian, Borrego-Diaz, Emma, Yamoutpoor, Farnaz, Meyer, Anna, Woo, Richard A, Pan, Weihong, Dudek, Arkadiusz Z, Olyaee, Mojtaba S, Esfandyari, Tuba, Farassati, Faris

“…Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a…”
Get full text

Identifying the main barriers for participation in a population-based colorectal cancer screening programme in East Azerbaijan, Iran by Dolatkhah, Roya, Somi, Mohammad Hossein, Dastgiri, Saeed, Jafarabadi, Mohammad Asghari, Sepehri, Bita, Shirmohammadi, Masoud, Nezamdoust, Marzieh, Abdolahi, Hossein Mashhadi, Farassati, Faris

“…Colorectal cancer (CRC) is the third most common cancer and the second leading cause of death worldwide. However, CRC is considered as one of the most…”
Get full text

Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer by Gholami, Nassrin, Sanaat, Zohreh, Dolatkhah, Roya, Nikanfar, Alireza, Esfahani, Ali, Danandehmehr, Amin, Akhrjou, Ashraf, Farassati, Faris

“…Introduction: It has been reported that Enhancer of Zeste Homolog 2 (EZH2) enhancer is expressed in Colorectal Cancer (CRC), but there are only limited…”
Get full text

RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC) by Ezzeldin, Mohamad, Borrego-Diaz, Emma, Taha, Mohammad, Esfandyari, Tuba, Wise, Amanda L., Peng, Warner, Rouyanian, Alex, Asvadi Kermani, Atabak, Soleimani, Mina, Patrad, Elham, Lialyte, Kristina, Wang, Kun, Williamson, Stephen, Abdulkarim, Bashar, Olyaee, Mojtaba, Farassati, Faris

“…Ral (Ras like) leads an important proto-oncogenic signaling pathway down-stream of Ras. In this work, RalA was found to be significantly overactivated in…”
Get full text

Development and Validation of Persian Risk Assessment Tool using National Comprehensive Cancer Network Guideline for Colorectal Cancer Screening by Dolatkhah, Roya, Dastgiri, Saeed, Jafarabadi, Mohammad Asghari, Abdolahi, Hossein Mashhadi, Sepehri, Bita, Shirmohammadi, Masoud, Farassati, Faris, Somi, Mohammad Hossein

“…Introduction: Despite evidence that early diagnosis of Colorectal Cancer (CRC) reduces the associated death burden, screening programs are uncommon even in…”
Get full text

Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer by Male, Heather, Patel, Vijay, Jacob, Mark A, Borrego-Diaz, Emma, Wang, Kun, Young, Derek A, Wise, Amanda L, Huang, Chao, Van Veldhuizen, Peter, O’Brien-Ladner, Amy, Williamson, Stephen K, Taylor, Sarah A, Tawfik, Ossama, Esfandyari, Tuba, Farassati, Faris

“…Abstract Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and relatively resistant to chemotherapy. The most prevalent molecular…”
Get full text

Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors by Bodempudi, Vidya, Yamoutpoor, Farnaz, Pan, Weihong, Dudek, Arkadiusz Z., Esfandyari, Tuba, Piedra, Mark, Babovick-Vuksanovic, Dusica, Woo, Richard A., Mautner, Victor F., Kluwe, Lan, Clapp, D. Wade, De Vries, George H., Thomas, Stacey L., Kurtz, Andreas, Parada, Luis F., Farassati, Faris

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Pro-oncogenic cell signaling machinery as a target for oncolytic viruses by Borrego-Diaz, Emma, Mathew, Rajesh, Hawkinson, Dana, Esfandyari, Tuba, Liu, Zhengian, Lee, Patrick W, Farassati, Faris

“…Viruses function in close harmony with the signaling machinery of their host. Upon exposure to the cell, a battery of viral products become engaged in boosting…”
Get more information

Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity by Yamoutpour, Farnaz, Bodempudi, Vidya, Park, Shay E, Pan, Weihong, Mauzy, Mary Jean, Kratzke, Robert A, Dudek, Arkadiusz, Potter, David A, Woo, Richard A, O'Rourke, Donald M, Tindall, Donald J, Farassati, Faris

“…Epidermal growth factor receptor variant III (EGFRvIII) is a constitutively active mutant form of EGFR that is expressed in 40% to 50% of gliomas and several…”
Get full text

Ras pathway activation in malignant mesothelioma by Patel, Manish R, Jacobson, Blake A, De, Arpita, Frizelle, Sandra P, Janne, Pasi, Thumma, Saritha C, Whitson, Brian A, Farassati, Faris, Kratzke, Robert A

“…Mutations in Ras family genes are rare in malignant mesothelioma. The role of activation of the Ras signaling pathway in the pathogenesis of mesothelioma is…”
Get more information

Abstract LB-16: Inhibition of RalA as a novel strategy for targeting ovarian cancer by Farassati, Faris

“…Abstract Abstract: The Ral (Ras like) GTPase guanyl nucleotide-binding proteins, RalA and RalB are direct effectors of pro-oncogene Ras. RalA and RalB are…”
Get full text

Editorial announcing PubMed indexing of Oncolytic Virotherapy by Farassati, Faris

“…Faris Farassati1,2 1Saint Luke’s Cancer Institute-Saint Luke’s Marion Bloch Neuroscience Institute, Kansas City, MO, USA; 2Midwest Biomedical Research…”
Get full text

Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids by MASHOUR, George A, DRISSEL, Stephanie N, FRAHM, Silke, FARASSATI, Faris, MARTUZA, Robert L, MAUTNER, Victor-F, KINDLER-RÖHRBORN, Andrea, KURTZ, Andreas

“…Neurofibromatosis type 1 (NF1) is a common genetic disorder of the nervous system resulting in neurofibromas and malignant peripheral nerve sheath tumors…”
Get full text

The role of KPNβ1 in neuro-oncology by Lilley, Megan, Farassati, Faris

“…Megan Lilley,1,2 Faris Farassati1,3 1Midwest Biomedical Research Foundation, Kansas City Veterans Affairs Medical Center, 2School of Medicine, University of…”
Get full text

The role of KPNβ 1 in neuro-oncology by Lilley, Megan, Farassati, Faris

Get full text